STEM CELL TREATMENT AND THERAPY FOR MS (MULTIPLE SCLEROSIS)
The type of MS that the person is afflicted with will determine what course of therapy we can offer, if any.
MS falls into different types including (i) Remitting Multiple sclerosis (RRMS), (ii) secondary progressive multiple sclerosis (SPMS), (iii) primary progressive multiple sclerosis (PPMS), and, (iv) progressive relapsing multiple sclerosis (PRMS).
Promising results and potential breakthroughs for MS have been recently reported by researchers worldwide.
For suitable candidates we offer an extensive treatment protocols for MS patients which includes the option of applying hundreds of millions of umbilical cord tissue cells, or harvesting and applying large quantities of mesenchymal stem cells, usually drawn from the patient’s own bone marrow. These treatments includes other supportive treatments and therapies with an aim to maximize the treatment effectiveness. Stem cells harvested from the patient’s own bone marrow will also be sent to a specialist COFEPRIS licensed laboratory for further cultivation, and differentiation for further injections.
We can also offer stem cell treatment using donor stem cells (including from the placenta and umbilical cord) which are provided from a licensed laboratory
Although stem cell treatment is not able to cure the disease, recipients of stem cell therapy have reported significantly slowed down disease progression, and improved motor function after stem cell transplantation.
Multiple Sclerosis (MS)
What is multiple sclerosis (MS)?
Multiple sclerosis (MS) is a chronic illness and autoimmune disease which involves a person’s central nervous system. In a person afflicted with MS the immune system attacks myelin, which is the protective layer found around nerve fibers.
This auto immune response causes inflammation and scar tissue, or lesions. This inhibits the ability of the brain to send nerve signals to the rest of the body.
People afflicted with MS experience a wide range of symptoms. Depending on the extent and nature of the disease symptoms vary widely from person to person.
MS falls into various categories such as remitting and progressive. Women are much more likely to suffer from MS than men. It is estimated that around one million people live with MS in the US alone.
Symptoms frequently change in severity from year to year, month to month, and even day to day.
Two of the most common symptoms are fatigue and ambulatory difficulties.
How can stem cells help treat MS
Currently, autoimmune conditions such as MS are treated with immune suppressive agents such as steroids, and other drugs, with varying degrees of success.
Researchers report that Stem cell therapy has been demonstrated to induce healing activity in animals and those with autoimmune disorders. Besides healing damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving its ability to fight off disease.
Stem cells and specifically, mesenchymal stem cells (MSCs) home in to inflamed tissue and start producing anti-inflammatory agents. It has been reported that this process acts locally and does not suppress the immune response of the person’s entire body.
Furthermore MSCs induce the production of T regulatory cells, which is a type of immune cell whose function is to protect the body against immunological self-attack.
Types of cells and mode of application
Our stem cell therapies involve the implanting of mesenchymal stem cells (MSCs) into the body via IV (intravenous), by intrathecal injection (spinal canal/subarachnoid space), or site injection (normally for joint issues). We offer various types of mesenchymal cells, from the umbilical cord, bone marrow or adipose fat. These stem cells can be autologous (originating from the patient’s own tissue) or allogeneic (originating from an outside source, such as umbilical cord tissue).
Researchers claim that Mesenchymal stem cells (MSCs) work in four main ways
- control inflammation
- Modulate the immune system
- stimulate regeneration
- reduce scarring
For more on MSCs click here.
What type of cells and how they are administered depends on the circumstances of each case.
Period of stay- length of protocol
The period of the patient stay also depends on the circumstances of each case and the condition treated. This can range from as few as 1-2 days or last for several weeks. Typically, the patient stay lasts for around 5 days. Patients traveling from say Europe will typically come for a longer period due to the issues of jet-lag. Due to our relative proximity to most parts of the US and Canada our patients can return for further treatments on a fairly regular basis. All patients are given a full medical examination upon arrival. The course of treatment also involves other treatments and techniques aimed at ameliorating and enhancing the effect of the stem cell infusion. We also offer a range of other subsidiary treatments that patients can benefit from during their stay- such as physiotherapy and other alternative therapies. Our IV treatments are minimally invasive.
As we explain at this link- these protocols are simply not available in the US and Canada and this is why we are in Baja California, Mexico.
We offer the option of staying in top rate accommodations either in an urban or beach front setting.
The amount of cells infused can vary- although at this time we typically infuse hundreds of millions of cells thru IVs and by injection. The state-of-the art licensed laboratories we work with and from whom we source our cells produce huge quantities of cells thru cultivating and expanding harvested cells. Cell expansion is the process of taking cells extracted from tissue, culturing them in the lab and encouraging them to reproduce. The reproduced cells are identical to the source cells, but this process allows more effective treatment with greater numbers of cells. This increases the possibility of a positive result.
Additional visits may be advised and as a consequence frequently patients are advised to return over time for more infusions.
All visits are subject to follow up by our team.
Safety of cord and other adult cells
Along with all adult stem cells, including those derived from bone marrow and adipose fat, no significant safety issues have been reported thru clinical trials and thru clinical use.
Researchers and treating doctors are satisfied that they are extremely safe. The only reported side effects being short term cases of nausea, fatigue etc… associated with all medical procedures. Contrast the situation with embryonic/fetal cell were there are fears that these cell types are potentially tumorigenic- i.e. can evolve into tumors. Due large part to this, researchers and regulators tend to be wary of them and focus on other stem cells types, such as cord, bone marrow, and fat.
This is one reason why we do not use fetal/embryonic cells.
To contact us for an initial consolation email: firstname.lastname@example.org or call +1 (619) 344 0565.